Myo-Inositol is not a new discovery. It has been studied for ovarian and metabolic health for over two decades. What has changed is our understanding of why dose matters — and why most supplements on the Indian market contain a fraction of the research dose.
What Myo-Inositol Does
Myo-Inositol is a naturally occurring sugar alcohol that functions as a second messenger in insulin signalling pathways. In ovarian tissue, it plays a critical role in FSH (follicle-stimulating hormone) signal transduction — the process by which follicles develop and mature during the menstrual cycle.
When insulin resistance is present (which is very common in women with hormonal imbalances), Myo-Inositol signalling is disrupted. Supplementing Myo-Inositol at clinical doses supports the restoration of normal insulin sensitivity in ovarian tissue, which in turn supports cycle regularity and ovarian function.
The 2000mg Dose
The most widely cited clinical research on Myo-Inositol for hormonal health has used doses of 2000–4000 mg per day. A 2019 meta-analysis in Gynecological Endocrinology reviewing 13 randomised controlled trials found that Myo-Inositol supplementation at these doses was associated with meaningful improvements in menstrual regularity and metabolic markers in women with hormonal concerns.
HerX contains 2000 mg of Myo-Inositol per serving (2 tablets). This is the minimum clinical dose in the literature. It is not a token inclusion.
The Berberis Vulgaris Addition
HerX also includes 20 mg of Berberis Vulgaris Root Extract — a standardised source of berberine. Berberine activates AMPK (AMP-activated protein kinase), an enzyme that acts as a cellular energy sensor and is central to insulin sensitivity regulation. The dual approach — Myo-Inositol for ovarian insulin signalling and Berberis for systemic AMPK activation — targets insulin resistance through complementary pathways.
What This Is Not
HerX is not a PCOS treatment. It is a nutraceutical formulation designed to support hormonal balance and insulin sensitivity through nutritional pathways. Women with diagnosed hormonal disorders should work with their gynaecologist. Nutritional support and medical care are not mutually exclusive — they are complementary.
